Facilitation of Extinction of Conditioned Fear by D-Cycloserine

  title={Facilitation of Extinction of Conditioned Fear by D-Cycloserine},
  author={Michael Davis and Karyn M. Myers and Kerry James Ressler and Barbara O. Rothbaum},
  journal={Current Directions in Psychological Science},
  pages={214 - 219}
Excessive fear and anxiety are characteristic of disorders such as post-traumatic stress disorder (PTSD) and phobias and are believed to reflect abnormalities in neural systems governing the development and reduction of conditioned fear. Conditioned fear can be suppressed through a process known as extinction, in which repeated exposure to a feared stimulus in the absence of an aversive event leads to a gradual reduction in the fear response to that stimulus. Like conditioned fear learning… 

Figures from this paper

An Examination of the Extended Effec ts of D- Cycloserine Treatment on Fear Extinction in Rats

Two experiments show that an initial learning must take place in order for DCS to be effective, and if there is certain sensitive population with which DCS can be efficacious, then an animal model of PTSD which utilizes DCS may be of limited value.

Augmentation treatment of psychotherapy for anxiety disorders with D-cycloserine.

Preliminary support for the use of acute dosing of DCS as an adjunctive intervention to exposure therapy for anxiety disorders, including specific phobia and social anxiety disorder is provided.

Harnessing reconsolidation to weaken fear and appetitive memories: A meta-analysis of post-retrieval extinction effects.

Findings to date support the continued translation of postretrieval extinction research to human and clinical applications, with particular application to the treatment of anxiety, traumatic stress, and substance use disorders.

Fear-Potentiated Startle

The effect of D-cycloserine on immediate vs. delayed extinction of learned fear.

It is suggested that aversive experiences prior to DCS administration can prevent it from facilitating extinction, and administering five, but not two, shocks prior to extinction training disrupted the facilitating effects of DCS on delayed extinction.

Immediate Extinction Attenuates Spontaneous Recovery and Reinstatement in a Passive Avoidance Paradigm

Two experiments investigated whether immediate extinction would prevent spontaneous recovery and reinstatement of fear using a passive avoidance paradigm to replicate and extend previous findings that immediate extinction attenuates spontaneous Recovery and reinstate of fear.

Post-extinction Delay Necessary to Induce Retrograde Amnesia for a Moderate Extinction Training Memory

The findings suggest that the extinction memory was active and susceptible to disruption 75 minutes after the extinction session, but the original fear memory may have been protected from the amnestic effects with sufficient time to reconsolidate.

Perceived control and avoidance in posttraumatic stress

A significant group × condition interaction effect, such that those with PTSD symptoms who were told they lacked control displayed greater avoidance of the subsequent stressor relative to those told they had control, suggests that ongoing experiences of uncontrollability may heighten psychological vulnerabilities implicated in PTSD.



D-cycloserine and the facilitation of extinction of conditioned fear: consequences for reinstatement.

Questions are raised about the mechanisms underlying DCS facilitation of extinction and the results suggest that DCS might have substantial practical benefit.

Inhibition of the Amygdala: Key to Pathological States?

Future therapies aimed at increasing inhibitory tone in the amygdala, either locally or via the prefrontal cortex, may prevent anxiety disorders and addiction relapse, and novel neuropeptides offer promise in this regard.

Extinction of fear-potentiated startle: blockade by infusion of an NMDA antagonist into the amygdala

The results show that infusion of the NMDA antagonist D,L-2- amino-5-phosphonovaleric acid (AP5) into the amygdala, a limbic structure known to be important for fear conditioning, dose-dependently blocked extinction of conditioned fear and suggest that an NMDA-dependent process might underlie the extinction of Conditioned fear.

Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear.

These pilot data provide initial support for the use of acute dosing of DCS as an adjunct to exposure-based psychotherapy to accelerate the associative learning processes that contribute to correcting psychopathology.

Facilitation of Conditioned Fear Extinction by Systemic Administration or Intra-Amygdala Infusions of d-Cycloserine as Assessed with Fear-Potentiated Startle in Rats

Results indicate that treatments that promote NMDA receptor activity after either systemic or intra-amygdala administration promote the extinction of conditioned fear.

Behavioral and Neural Analysis of Extinction

Effects of D-cycloserine on extinction of conditioned freezing.

The results suggest that DCS facilitates extinction of conditioned freezing by acting on consolidation processes partly mediated by the basolateral amygdala, and the dose-response curve for this effect was linear.

Consolidation of Extinction Learning Involves Transfer from NMDA-Independent to NMDA-Dependent Memory

It is suggested that consolidation of extinction involves off-line relearning that reinforces extinction memory through NMDA-mediated plasticity, perhaps in prefrontal–amygdala circuits.

The amygdala: vigilance and emotion

A review of available studies examining the human amygdala covers both lesion and electrical stimulation studies as well as the most recent functional neuroimaging studies, and attempts to integrate basic information on normal amygdala function with the current understanding of psychiatric disorders, including pathological anxiety.

A double-blind switch study of paroxetine and venlafaxine in obsessive-compulsive disorder.

The first double-blind switch study of 2 SRIs in patients with OCD shows that 42% of the nonresponders benefited from a crossover to the other SRI, and that paroxetine was more efficacious than venlafaxine in the treatment of non responders to a previous SRI trial.